Federal contract award
75F40124F19039
1-YEAR, FIRM-FIXED PRICE (FFP) TYPE TASK ORDER FOR INCIDENTS REVIEW SUPPORT TO SUPPORT THE FDA/ CENTER FOR DRUG EVALUATION & RESEARCH/OFFICE OF COMPLIANCE.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541990 — All Other Professional, Scientific, and Technical Services |
| PSC | R499 — Other Professional Services |
| Parent award / vehicle | 75F40120D00022 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $790.8K |
| Current contract value | $790.8K |
| Potential contract value / ceiling | $790.8K |
| Start date | Aug 20, 2024 |
| Current end date | Mar 31, 2026 |
| Potential end date | Mar 31, 2026 |
| Latest award activity | Jan 21, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 21, 2026 | P00003 | $0 | FIRM-FIXED PRICE (FFP) TYPE TASK ORDER FOR INCIDENTS REVIEW SUPPORT TO SUPPORT THE FDA/ CENTER FOR DRUG EVALUATION & RESEARCH/OFFICE OF COMPLIANCE. PERIOD OF PERFORMANCE CORRECTION. |
| Sep 30, 2025 | P00002 | $100.0K | 1-YEAR, FIRM-FIXED PRICE (FFP) TYPE TASK ORDER FOR INCIDENTS REVIEW SUPPORT TO SUPPORT THE FDA/ CENTER FOR DRUG EVALUATION & RESEARCH/OFFICE OF COMPLIANCE. |
| Jul 29, 2025 | P00001 | $0 | 1-YEAR, FIRM-FIXED PRICE (FFP) TYPE TASK ORDER FOR INCIDENTS REVIEW SUPPORT TO SUPPORT THE FDA/ CENTER FOR DRUG EVALUATION & RESEARCH/OFFICE OF COMPLIANCE. |
| Aug 20, 2024 | 0 | $690.8K | 1-YEAR, FIRM-FIXED PRICE (FFP) TYPE TASK ORDER FOR INCIDENTS REVIEW SUPPORT TO SUPPORT THE FDA/ CENTER FOR DRUG EVALUATION & RESEARCH/OFFICE OF COMPLIANCE. |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.